# A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

> **NCT06979180** · NA · RECRUITING · sponsor: **Papillex Inc.** · enrollment: 60 (estimated)

## Conditions studied

- CIN - Cervical Intraepithelial Neoplasia
- CIN 1
- CIN 2
- HPV
- Cervical Cells

## Interventions

- **DIETARY_SUPPLEMENT:** Papillex®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06979180
- **Lead sponsor:** Papillex Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979180, "A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06979180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*